Preview Mode Links will not work in preview mode

Clinical Literature Summaries presented by InpharmD™ (S3)


Dec 22, 2021

An open-label, randomized, parallel-group, adaptive design with blinded outcome adjudication trial conducted to compare the efficacy and safety of milvexian and enoxaparin in patients undergoing elective knee arthroplasty.